Basic information Safety Supplier Related

Pasotuxizumab

Basic information Safety Supplier Related

Pasotuxizumab Basic information

Product Name:
Pasotuxizumab
Synonyms:
  • Pasotuxizumab
  • Research Grade Pasotuxizumab (DHG01301)
  • Research Grade Pasotuxizumab
CAS:
1442657-12-6
MW:
0
Mol File:
Mol File
More
Less

Pasotuxizumab Chemical Properties

form 
Liquid
color 
Colorless to light yellow
More
Less

Pasotuxizumab Usage And Synthesis

Uses

Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC)[1][2].

in vivo

Pasotuxizumab (0-100 ng/mL approximately, 48 h) leads to activation of CD4+ and CD8+ T cell populations, with EC50s of 3.4-6.7 ng/mL for human cocultures, and 13.7-21.2 ng/mL for cynomolgus monkey cell cocultures[2].
Pasotuxizumab (0-100 ng/mL approximately, 48 h) increases release of interferon-γ, TNF-α, IL-2 and IL-10 in T cells[2].

Animal Model:PC-3-huPSMA mouse xenograft model[2]
Dosage:0.005-5 mg/kg
Administration:i.v., once daily
Result:Inhibited tumor growth by 86% (0.005 mg/kg/d) and 99% (5 mg/kg/d).
Animal Model:BALB/c mice (PK Assay)[2]
Dosage:0.1, 0.3, and 1 mg/kg
Administration:i.v. bolus administration or s.c.
Result:Pharmacokinetic profile of Rafivirumab.
Dose (mg/kg)AUC (mg h/L)CLmatrix (L/h/kg) T1/2 (h) F (%)
i.v. (0.3) 0.93 0.329.7100
s.c. (0.3)0.171118

References

[1] Horst-Dieter Hummel, et al. Phase 1 study of pasotuxizumab (BAY 2010112), a PSMA-targeting Bispecific T cell Engager (BiTE) immunotherapy for metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology 2019 37:15_suppl, 5034-5034.
[2] Friedrich M, et al. Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigens. Mol Cancer Ther. 2012 Dec;11(12):2664-73. DOI:10.1158/1535-7163.MCT-12-0042

PasotuxizumabSupplier

ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Email
2853530910@QQ.com
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Email
422450190@qq.com
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
More
Less

Pasotuxizumab(1442657-12-6)Related Product Information